Sensitive periods in development and risk for psychiatric disorders and related endpoints: A systematic review of child maltreatment findings
Your Content Goes Here Childhood maltreatment increases the [...]
Down Syndrome Program: new research paper on COVID-19 in group homes
Your Content Goes Here For the past 2 [...]
Nucleosides Associated With Incident Ischemic Stroke in the REGARDS and JHS Cohorts
Your Content Goes Here This manuscript is the [...]
Polygenic risk scores for diverse cohorts
Your Content Goes Here Even though the application [...]
Brain-specific deletion of GIT1 impairs cognition and alters phosphorylation of synaptic protein networks implicated in schizophrenia susceptibility
Your Content Goes Here The molecular and cellular [...]
Distinct effects of interleukin-6 and interferon-γ on differentiating human cortical neurons
The Karmacharya lab interrogated neurodevelopmental effects of exposure to interleukin-6 (IL-6) and interferon-γ (IFN-γ) in differentiating human cortical neurons.
Riboflavin depletion promotes longevity and metabolic hormesis in Caenorhabditis elegans
Your Content Goes Here This study makes a [...]
Tissue-specific and repeat length-dependent somatic instability of the X-linked dystonia parkinsonism-associated CCCTCT repeat
Your Content Goes Here The length of a [...]
The Center for Genomic Medicine (CGM) comprises one of the largest and most vibrant hubs of genomic medicine research in the world. The CGM includes 46 faculty collaborating to define the ‘genomic medicine cycle’ – which envisages a genomics community seeking to advance research from basic genomics research to ultimately using genome information for diagnostics and targeted therapeutics. All of our investigators are faculty at Harvard Medical School, and many members of our community are also investigators at the Broad Institute of Harvard and MIT.
